Reduction in the MK-801 binding sites of the NMDA sub-type of glutamate receptor in a mouse model of congenital hyperammonemia: Prevention by acetyl-L-carnitine

Neuropharmacology

Volumn 38, Issue 3, 1999, Pages 383-394

  Rama Rao, K V ^a   Qureshi, I A ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Acetyl L carnitine; Excitotoxicity; Glutamate; NMDA receptors; Ornithine transcarbamylase; spf mouse

Indexed keywords

4 AMINOPYRIDINE; DIZOCILPINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; LEVACECARNINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; ORNITHINE CARBAMOYLTRANSFERASE; VERATRIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DRUG BINDING SITE; DRUG RECEPTOR BINDING; HYPERAMMONEMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC MEMBRANE;

ACETYLCARNITINE; ADENOSINE TRIPHOSPHATE; AGING; AMINO ACID METABOLISM, INBORN ERRORS; AMMONIA; ANIMALS; CEREBRAL CORTEX; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; KINETICS; MICE; MICE, MUTANT STRAINS; NOOTROPIC AGENTS; ORNITHINE CARBAMOYLTRANSFERASE; RECEPTORS, N-METHYL-D-ASPARTATE; REFERENCE VALUES; SYNAPTIC MEMBRANES;

EID: 0032978522     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00160-9     Document Type: Article

References (58)

1. Amador, M., Dani, J.A., 1991. MK-801 inhibition of acetylcholine receptor channels. Synapase 7, 207-215.
2. Batshaw, M.L., Robinson, M.B., Hyland, K., Djali, S., Hyes, M.P., 1993. Quinolinic acid in children with congenital hyperammonemia. Ann. Neurol. 34, 676-681.
3. Beal, M.F., 1992. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31, 119-130.
4. Brusilow, S.W., Horwich, A.L., 1995. Urea cycle enzymes. In: Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D. (Eds.), The Metabolic and Molecular Bases of Inherited Disease. McGraw Hill, New York, pp. 1187-1232.
5. Brusilow, S.W., Maestri, N.B., 1996. Urea cycle disorders: diagnosis, pathophysiology, and therapy. Adv. Pediatr. 43, 127-170.
6. Castorina, M., Ambrosini, C.M., Giuliani, A.M., Pacifici, L., Ramacci, M.T., Angelucci, L., 1993. A cluster analysis study of acetyl-L-carnitine effect on NMDA receptors in aging. Exp. Gerontol. 28, 537-548.
7. Castorina, M., Ferraris, L., 1994. Acetyl-L-carnitine affects aged brain receptorial system in rodents. Life Sci. 54, 1205-1214.
8. Colucci, W.J., Gandour, R.D., 1988. Carnitine acetyltransferase: a review of its biology, enzymology, and bioorganic chemistry. Bioorg. Chem. 16, 307-334.
9. +-gradients and neurotransmitter amino acid levels in isolated rat brain synaptosomes. J. Neurochem. 49, 1229-1241.
10. Davis, S., Markoswka, D.S., Wenk, G.L., Barnes, C.A., 1993. Acetyl-L-carnitine: behavioral, electrophysiological, and neurochemical effects. Neurobiol. Aging 14, 107-115.
11. De Knegt, R., Schalm, S.W., van der Rijt, C.C.D., Fekkes, D., Dalm, E., Hekking-Weyma, I., 1994. Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure: an experimental study based on in vivo brain dialysis. J. Hepatol. 20, 19-26.
12. DeMars, R., LeVan, S.L., Trend, B.L., Russell, L.B., 1976. Abnormal ornithine carbamoyltransferase in mice having the sparse-fur mutation. Proc. Natl. Acad. Sci. USA 73, 1693-1697.
13. Dolezal, V., Tucek, S., 1981. Utilization of acetylcarnitine, citrate, acetate, pyruvate and glucose for the synthesis of acetylcholine in rat brain. J. Neurochem. 36, 1323-1330.
14. Dunkley, P.R., Jarvic, P.E., Heath, J.W., Kidd, G.J., Rostas, J.A.P., 1986. A rapid method for isolation of synaptosomes on percoll gradients. Brain Res. 372, 115-129.
15. Erecinska, M., 1987. The neurotransmitter amino acid transport systems: a fresh outlook on an old problem. Biochem. Pharmacol. 36, 3547-3555.
16. Fiori, L., Rampello, L., 1989. L-Acetylcarnitine attenuates the age-dependent decrease of NMDA-sensitive glutamate receptors in rat hippocampus. Acta Neurol. (Napoli) 5, 346-350.
17. Forloni, G., Angeretti, N., Smiroldo, S., 1994. Neuroprotective activity of acetyl-L-carnitine: studies in vitro. J. Neurosci. Res. 37, 92-96.
18. Gushiken, T., Yoshimura, N., Saheki, T., 1985. Transient hyperammonemia during aging in ornithine transcarbamylase-deficient, sparse-fur mice. Biochem. Intl. 5, 637-643.
19. Inoue, I., Gushiken, T., Kobayashi, K., Saheki, T., 1987. Accumulation of large neutral amino acids in the brain of sparse-fur mice at hyperammonemic state. Biochem. Med. Metab. Biol. 38, 378-386.
20. Knecht, K., Michalak, A., Rose, C., Rothstein, J.D., Butterworth, R.F., 1997. Decreased glutamate transporter (GLt 1) expression in frontal cortex of rats with acute liver failure. Neurosci. Lett. 229, 201-203.
21. +-ATPase. J. Neurochem. 63, 2172-2178.
22. +-dependent binding of glutamate in rat cortical and hippocampal synaptic membranes. Neurosci. Lett. 158, 113-116.
23. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with folin-phenol reagent. J. Biol. Chem. 193, 265-275.
24. Ludolph, A.C., Riepe, M., Ullrich, K., 1993. Excitotoxicity, energy metabolism and neurodegeneration. J. Inher. Metab. Dis. 16, 716-723.
25. McNaught, K.S.P., Brown, G.C., 1998. Nitric oxide causes glutamate release from brain synaptosomes. J. Neurochem. 70, 1541-1546.
26. Minana, M.-D., Hermenegildo, C., Llansola, M., Montoliu, C., Grisolia, S., Felipo, V., 1996. Carnitine and choline derivatives containing a trimethylamine group prevent ammonia toxixity in mice and glutamate toxicity in primary cultures of neurons. J. Pharmacol. Expt. Ther. 279, 194-199.
27. Moroni, F., Lombardi, G., Moneti, G., Cortesini, C., 1983. The release and neosynthesis of glutamic acid increased in Experimental models of hepatic encephalopahty. J. Neurochem. 40, 850-854.
28. Morsy, M.A., Caskey, C.T., 1994. Ornithine transcarbamylase deficiency: a model for gene therapy. In: Felipo, V., Felipo, S. (Eds.), Hepatic Encephalopathies, Hyperammonemia and Ammonia Toxicity. Grisolia, Plenum Press, New York, pp. 145-154.
29. Nicholls, D.G., Sihra, T.S., Sanchez-Prieto, J., 1987. Calcium dependent and independent release of glutamate from synaptosomes monitored by continuous fluorometry. J. Neurochem. 49, 50-57.
30. Norenberg, M.D., Huo, Z., Neary, J.T., Roig-Cantesano, A., 1997. The glial glutamate transporter in hyperammonemia and hepatic encephalopathy. Relation to energy metabolism and glutamatergic neurotransmission. Glia 21, 124-133.
31. 3H]glutamate binding sites in rat brain following portacaval anastomosis. J. Neurochem. 55, 386-390.
32. 3H] MK-801 binding sites in postmortem human brain. J. Neurochem. 54, 1163-1168.
33. Qureshi, I.A., Letarte, J., Ouellet, R., 1979. Ornithine transcarbamylase deficiency in mutant mice I. Studies on the characterization of enzyme defect and suitability as animal model of human disease. Pediatr. Res. 13, 807-811.
34. Qureshi, I.A., Rao, K.V.R., 1997. Decreased activities of electron transport chain complexes in synaptosomes and non-synaptic mitochondria in congenitally hyperammonemic spf mice: restoration by acetyl-L-carnitine. Proceedings of Advances in Inherited Urea Cycle Disorders, held at Vienna, Austria, pp.44.
35. Ramoa, A.S., Alkondon, M., Irons, J., Lunt, G.G., Deshpande, S.S, Wonnacott, S., Aronstam, R.S., Abbuquerque, E.X. 1990. The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. J, Pharmacol. Exp. Ther. 254, 71-82.
36. 3H]PK11195 in congenital ornithine transcarbamylase-deficient sparse fur mouse. Pediatr. Res. 34, 777-780.
37. Rao, K.V.R., Mawal, Y.R., Qureshi, I.A., 1997. Progressive decrease of cerebral cytochrome C oxidase activity in sparse-fur mice: role of acetyl-L-carnitine in restoring the ammonia-induced cerebral energy depletion. Neurosci. Lett. 224, 83-86.
38. Rao, K.V.R., Murthy, Ch.R.K., 1994. Synaptosomal high affinity transport systems for essential amino acids in rat brain cortex. Neurosci. Lett. 175, 103-106.
39. Rao, V.L.R., Agrawal, A.K., Murthy, Ch.R.K., 1991. Ammonia-induced alterations in glutamate and muscimol binding to cerebellar synaptic membranes. Neurosci. Lett. 130, 251-254.
40. Ratnakumari, L., Qureshi, I.A., Maysinger, D., Butterworth, R.F., 1995. Developmental deficiency of the cholinergic system in congenitally hyperammonemic spf mice: effect of acetyl-L-carnitine. J. Pharmacol. Exp. Ther. 274, 437-443.
41. 3H]MK801 binding site in brain in congenital ornithine transcarbamylase deficiency. Metab. Brain Dis. 10, 249-255.
42. +-ATPase activities are increased in brain in both congenital and acquired hyperammonemic syndromes. Neurosci. Lett. 197, 89-92.
43. 2 receptor changes in congenital ornithine transcarbamylase deficiency. Pediatr. Res. 40, 25-28.
44. Ratnakumari, L., Qureshi, I.A., Butterworth, R.F., 1993. Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy. Metabolism 42, 1039-1046.
45. Ratnakumari, L., Qureshi, I.A., Butterworth, R.F., 1992. Effects of congenital hyperammonemia on the cerebral and hepatic levels of the intermediates of energy metabolism in spf mice. Biochem. Biophys. Res. Commun. 184, 746-751.
46. Ratnakumari, L., Qureshi, I.A., Butterworth, R.F., 1994. Evidence for cholinergic neuronal loss in brain in congenital ornithine transcarbamylase deficiency. Neurosci. Lett. 178, 63-65.
47. Ratnakumari, L., Qureshi, I.A., Butterworth, R.F., 1994a. Regional amino acid neurotransmitter changes in brains of spf/Y mice with congenital ornithine transcarbamylase deficiency. Metab. Brain Dis. 9, 43-51.
48. Robinson, M.B., Hopkins, K., Batshaw, M.L., McLaughlin, B.A., Heyes, M.P., Oster-Granite, M.L., 1995. Evidence of excitotoxicity in the brain of ornithine carbamoyltransferase deficient sparse fur mouse. Dev. Brain Res. 90, 35-44.
49. Rosenthal, R.E., Williams, R., Bogaert, Y.E., Getson, P.R., Fiskum, G., 1992. Prevention of postischemic canine neurological injury through potentiation of brain energy metabolism by acetyl-L-carnitine. Stroke 23, 1312-1318.
50. Sandoval, M.E., Horch, P., Cotman, C.W., 1978. Evaluation of glutamate as a hippocanpal neurotransmitter: glutamate uptake and release from synaptosomes. Brain Res. 142, 285-299.
51. Schmidt, W., Wolf, G., Grungreiff, K., Meier, M., Reum, T., 1990. Hepatic encephalopathy influences high-affinity uptake of transmitter glutamate and aspartate into the hippocampal formation. Metab. Brain Dis. 5, 19-31.
52. Scorziello, A., Meucci, O., Calvani, M., Schettini, G., 1997. Acetyl-L- carnitine arginine amide prevents β25-35-induced neurotoxicity in cerebellar granule cells. Neurochem. Res. 22, 257-265.
53. Sima, A.A., Ristic, H., Merry, A., Kamijo, M., Lattimer, S.A., Stevens, M.J., Greene, D.A., 1996. Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat. J. Clin. Invest. 97, 1900-1907.
54. Spagnoli, A., Lucca, U., Menasce, G., et al., 1991. Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology 41, 1726-1732.
55. 3H] pyperidine binding to the N-methyl-D-aspartate receptor complex in human brain. J. Neurochem. 56, 1248-1254.
56. Tymianski, M., Tator, C.H., 1996. Normal and abnormal calcium homeostasis in neurons: a basis for the pathophysiology of traumatic and ischemic central nervous system injury. Neurosurgery 38, 1176-1195.
57. Ye, X., Robinson, M.B., Batshaw, M.L., Furth, E.E., Smith, I., Wilson, J.M., 1996. Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors. J. Biol. Chem. 271, 3639-3646.
58. Ye, X., Robinson, M.B., Pabin, C., Quinn, T., Jawad, A., Wilson, J.M., Batshaw, M.L., 1997. Adenovirus-mediated in vivo gene transfer rapidly protects ornithine transcarbamylase-deficient mice from an ammonium challenge. Pediatr. Res. 41, 527-534.